Watch Nurse B & Nurse K explain it here!

Semaglutide and tirzepatide are both similar peptides that work to reduce weight and improve blood sugar control. They both are GLP-1 receptor agonists - meaning that they both stimulating insulin secretion and reducing glucagon production. It also slows down digestion, leading to better blood sugar control.

Where they differ is that tirzepatide is a dual GIP and GLP-1 receptor agonist. It targets both pathways to potentially provide additional benefits in terms of glucose control and weight management.

While both medications share common goals in promoting weight loss, the choice between semaglutide and tirzepatide often depends on individual patient factors, preferences, and the prescribing healthcare professional's recommendations.

In clinical studies, individuals using semaglutide have shown significant weight loss over a period of time. The exact amount and speed of weight loss can depend on factors such as individual metabolism, adherence to a healthy diet, physical activity levels, and overall health.

Typically, people may start to see weight loss within a few weeks to months of using semaglutide. However, it's important to note that medication alone is not a substitute for a healthy lifestyle, including a balanced diet and regular exercise.

Semaglutide and tirzepatide, like any medication, may cause side effects. Possible side effects of semaglutide and tirzepatide can include - nausea, vomiting, diarrhea, heartburn, abdominal pain, decreased appetite, and hypoglycemia.

Slowly increasing the dose of semaglutide and tirzepatide per your provider’s recommendation and adhering to a balanced diet and water intake helps minimize the potential for these side effects.

The potential for weight gain after stopping semaglutide or tirzepatide can vary among individuals and depends on several factors, including lifestyle, diet, and overall health. Semaglutide is a medication that has shown efficacy in promoting weight loss, and its impact on weight maintenance after discontinuation may be influenced by how well lifestyle changes are sustained.

While semaglutide and tirzepatide can help with weight loss by reducing appetite and promoting a feeling of fullness, once the medication is stopped, there may be a risk of gradual weight regain if healthy habits are not maintained. It's essential to emphasize that any weight loss strategy should ideally be part of a comprehensive plan that includes a balanced diet and regular physical activity.

To minimize the risk of regaining weight after discontinuing semaglutide of tirzepatide, consider the following:

1. Healthy diet: Continue to follow a balanced and nutritious diet, incorporating a variety of foods that support overall well-being.

2. Regular exercise: Engage in regular physical activity to help maintain a healthy weight and promote overall health.

3. Medical guidance: Always consult with your healthcare provider before stopping semaglutide or tirzepatide. They can provide guidance on the most appropriate course of action based on your individual health needs.

It's important to recognize that medications alone are not a substitute for a healthy lifestyle. Long-term weight maintenance requires ongoing efforts to adopt and sustain positive lifestyle changes.

To maintain your weight loss results from semaglutide or tirzepatide it is important to commit to regular exercise and a healthy diet.

Exercising for 30 min a day with weight lifting and cardio workouts help with weight loss and maintaining a healthy weight.

Adhering to a healthy diet that is high in protein and reduced fried, processed, and sugary foods. Also ensuring adequate water intake up to 3L/day.

Our current pricing for semaglutide starts at $299/mo and tirzepatide starts at $550/mo. Your dose is slowly titrated up on a monthly basis and pricing increases with the dose increase.

To start weight loss management with us via semaglutide or tirzepatide we require an in-person consultation with one of our nurse practitioners to ensure that injections would be safe for you. At this appointment we ask that you bring in recent blood work (within 1 year) that includes a CBC, CMP, TSH, lipid panel, A1C, and fasting blood sugar.

Patients that are pregnant, breastfeeding, or planning, or have a thyroid disorder are not candidates for our weight loss treatment.

You will be provided with weekly injections and you will be seen by one of our providers every 4 weeks to manage your care and assess your weight and vitals.

It is important that your dose is managed by one of our medical providers and titrated up or down per medical recommendation.